GLP-1 Microdosing: Why Doctors Are Genuinely Split in 2026

A plastic surgeon on TV says everyone should be doing it, even people who don't need it. A UCLA physician calls the exact same thing "experimental and unauthorized." Both are talking about the same trend: microdosing Ozempic and similar drugs. Let's look at what's actually happening, and why doctors themselves can't agree.

What GLP-1 Medications Actually Do

GLP-1 receptor agonists, the drug family behind Ozempic, Wegovy, Mounjaro, and Zepbound, mimic a natural hormone your body already makes. They help regulate blood sugar, slow down stomach emptying, and signal fullness to your brain. In practical terms, they reduce appetite, help people feel full sooner, and support weight loss. Many patients also describe a reduction in what's often called "food noise," the constant mental chatter about food and cravings.

These medications were developed and tested at specific, standard doses. A typical starting dose of Ozempic is 0.25 milligrams weekly. A typical starting dose of Mounjaro is 2.5 milligrams weekly.

What "Microdosing" Actually Means Here

Microdosing means taking a smaller amount than what's prescribed, or spacing doses out longer than recommended. With GLP-1s, this looks like staying on a very low starter dose long-term, taking less than a doctor prescribed, or injecting less frequently than the standard schedule.

People are drawn to this for a few specific, understandable reasons: reducing side effects like nausea and stomach pain, saving money on medications that can cost around $1,000 a month without insurance, and easing into a higher dose more gradually.

The Doctor Publicly Promoting It

Dr. Terry Dubrow, a plastic surgeon and television personality, told Fox News Digital he's "obsessed with the concept of microdosing." His specific suggestion: roughly half the standard diabetes starting dose, taken every 10 days instead of every 7, even for people who don't have diabetes or need to lose weight.

Bryan Johnson, a venture capitalist and longevity-focused content creator, has publicly described microdosing Ozempic himself, acknowledging a real side effect: it raised his resting heart rate by two to three beats per minute, something he described as meaningful for him personally, while still saying he found the tradeoff worthwhile.

The Doctors Pushing Back, Directly

Here's where the honest picture gets more complicated. UCLA internal medicine doctors Eve Glazier and Elizabeth Ko have described microdosing GLP-1 drugs plainly as "experimental and unauthorized."

At the American Association of Clinical Endocrinology's Annual Scientific and Clinical Conference in April 2026, clinical pharmacist Anne Komé presented directly on this trend's risks. Her documented concerns included dosing errors, contamination risk, and a genuine lack of efficacy and safety data at these lower doses. Her stated position: microdosing can be beneficial for certain patients in specific, careful circumstances, but healthcare professionals need real caution, since the supporting data simply isn't there yet.

Dr. Jeff Bohmer, medical director of the emergency department at Northwestern Medicine Central DuPage Hospital, offered a more measured middle position: he understands the financial appeal of stretching out an expensive medication, but was direct that there aren't strong studies yet to support the practice.

The Honest Answer to "Does It Actually Work?"

According to Tufts Medicine's Dr. Caitlin Polistena, Medical Director of the Bariatric Surgery Program at Lowell General Hospital, the honest answer is straightforward: there isn't strong research showing very low doses are effective for sustained weight loss. Most clinical trials for these medications tested the standard, approved doses, not the lower amounts people are now experimenting with on their own.

That's an important distinction. The medications themselves have real, well-documented clinical trial data behind their approved doses. Microdosing takes those same medications outside the specific doses and schedules that data actually covers.

Why This Is Genuinely More Complicated Than Most Trends

Most wellness trends involve a supplement or a lifestyle change, low individual risk if it doesn't work. This one is different, because it involves real, prescription-only medications being used outside their studied, approved parameters, without the same body of safety data backing that specific use.

An endocrinologist told one outlet that patients have started asking about microdosing specifically to try to prevent conditions like Alzheimer's, a use case entirely outside what these medications have been studied or approved for. That's a meaningful gap between what a medication has demonstrated evidence for, and what a trend has started to promise it might also do.

What a More Cautious Approach Actually Looks Like

The clinical pharmacist presentation at the AACE conference specifically emphasized three things as essential if microdosing is considered at all: careful patient selection, extensive education about what isn't yet known, and consistent medical monitoring throughout. In plain terms, this isn't something to self-manage by copying an influencer's routine or a specific number mentioned on a podcast.

The Honest Bottom Line

GLP-1 microdosing sits at a genuinely unresolved point in medicine right now. Real, credentialed doctors are publicly landing on different sides of it, some cautiously open to it under close supervision, others calling it outright unauthorized and experimental. What both sides consistently agree on: the safety and effectiveness data for these lower, non-standard doses simply doesn't exist yet at the same level as the data behind the approved, standard doses. That gap is the single most important thing to understand before treating this as a settled, safe practice.

Now It's Your Turn

Have you looked into GLP-1 microdosing, or talked to your doctor about it? Share your experience or questions in the comments below. I read every single one.

A quick note: this article shares general health information based on current expert commentary, not medical advice. GLP-1 medications are prescription drugs. Please talk to a qualified healthcare professional before making any changes to a prescribed medication regimen.